MTOR and nonpapillary renal cell carcinoma: In conclusion, the present study provided a comprehensive overview of the OS biomarkers found in the PI3K/AKT/mTOR signaling pathway, which highlighted the potential role of this pathway in ccRCC progression and targeted therapy.